allogeneic cell therapy

dollar sign with colored arrows in a maze
Biotech

Cell therapy biotech bags $102M to fund phase 3 epilepsy plans

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.
Gabrielle Masson Apr 3, 2025 1:22pm
Abstract modern white spiral clock dial with roman and arabic numerals

Cell therapy biotech axes cancer trial, turns to autoimmune

Mar 19, 2025 5:35pm
whale jumping out of water

Orca prepares to make market plunge after phase 3 win

Mar 17, 2025 7:00am
Abstract 3D Geometric Shapes Cube Blocks Background

Takeda's oncology execs sharpen focus after restructuring

Mar 13, 2025 10:59am
A series of dice with a bag on them illustrating cost cuts

Atara, reeling from FDA hold on Ebvallo, halves workforce

Mar 4, 2025 8:07am
gold arrow pointing upward forward

Sana stock price triples after allogeneic cell therapy data drop

Jan 8, 2025 10:38am